{"id":"https://genegraph.clinicalgenome.org/r/f963bfe7-9793-4da7-9b34-963c90be7bb7v1.1","type":"EvidenceStrengthAssertion","dc:description":"CLCN7 was first reported in relation to autosomal dominant CLCN7-related osteopetrosis in 2001 (BÃ©nichou et al.: PMID: 11468688). The condition is characterized by increased bone density leading to bone fragility, as well as the \"rugger jersey spine\" and \"bone within bone\" on iliac wings, as evident in radiographs. AD CLCN7-related osteopetrosis is associated with reduced penetrance and a milder phenotype than the recessive form. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in phenotypic variability and inheritance pattern between disease assertions. Therefore, the following entities have been split into multiple disease entities: autosomal dominant osteopetrosis 2 (OMIM: 166600); autosomal recessive osteopetrosis 4 (OPTB4, OMIM: 611490); and autosomal dominant Hypopigmentation, Organomegaly, and Delayed Myelination and Development (HOD; OMIM: 618541). The split curations for autosomal recessive OPTB4 and autosomal dominant HOD have been curated separately. 12 variants (missense, frameshift) that have been reported in 37 probands in 7 publications (PMIDs: 11468688, 11741829, 21947783, 21962762, 30229577, 30942407, 36051116) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be dominant negative. This gene-disease relationship is also supported by experimental evidence, including mouse models showing increased bone density in mutants (PMIDs: 24185277, 28942122). In summary, there is definitive evidence supporting the relationship between CLCN7 and autosomal dominant osteopetrosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date 12/4/23 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f963bfe7-9793-4da7-9b34-963c90be7bb7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/23840c1f-9d30-4ccf-9fc0-604a0cb12eb4","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/23840c1f-9d30-4ccf-9fc0-604a0cb12eb4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2024-01-22T17:51:10.111Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/23840c1f-9d30-4ccf-9fc0-604a0cb12eb4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-12-04T17:00:00.000Z","role":"Approver"}],"curationReasonDescription":"The genetic evidence should total 12.6 pts., with the maximum of 12.0 pts. counted (not 10.6 pts.), as I upgraded 2.0 pts. (0.5 pts. each) for the hotspot variants: p.Pro249Leu, p.Arg286Trp, p.Arg767Trp, and p.Tyr99Cys).","curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23840c1f-9d30-4ccf-9fc0-604a0cb12eb4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23840c1f-9d30-4ccf-9fc0-604a0cb12eb4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf97777f-f9ad-44a6-b55b-0476fc9185c0","type":"EvidenceLine","dc:description":"The score was upgraded due to the specificity and multiple pieces of evidence. The findings of poor resorption and increased bone density were also observed in the mouse model of the heterozygous mutant p.Gly213Arg (the mice homolog of the mutation p.Gly215Arg, scored in the genetic evidence) (PMID: 24185277; Alam et al., 2014). As another note, the heterozygous mice have a milder phenotype than the homozygous p.Phe318Leu or compound heterozygous p.Phe318Leu/p.Gly213Arg mice. The homozygous mutants die within the first month of life. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfa61482-3173-40b7-9506-abe6cd222472","type":"Finding","dc:description":"The increased density of osteoclasts and increased bone volume seen in the mice recapitulate the phenotype in humans. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28942122","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/23840c1f-9d30-4ccf-9fc0-604a0cb12eb4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd78fe1d-65c4-4a6a-8bdb-edd4e7b662bf","type":"EvidenceLine","dc:description":"I already counted the functional evidence, but the score for this proband should still be 1 (0.5 for being de novo + 0.5 for the radiographic evidence). Radiographic evidence indicates thickening of cortex and narrowing of medullary cavity in pelvis and both femurs. Images also show high bone density in thoracic and lumbar vertebrae, as well as on both sides of the ribs. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd78fe1d-65c4-4a6a-8bdb-edd4e7b662bf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36051116","allele":{"id":"https://genegraph.clinicalgenome.org/r/32da6a0c-d3b2-42e9-86ce-397c3ffdf2ac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.746C>T (p.Pro249Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394191132"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/bd78fe1d-65c4-4a6a-8bdb-edd4e7b662bf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells (PMID: 11741829; Cleiren et al., 2001). ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a7f8b4e5-a0d8-4453-9aec-02e1ef070c33","type":"EvidenceLine","dc:description":"Radiographic evidence of spine and pelvis indicates increased bone density. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7f8b4e5-a0d8-4453-9aec-02e1ef070c33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","allele":{"id":"https://genegraph.clinicalgenome.org/r/f570b117-404c-423f-b62b-6492c1c158ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.643G>A (p.Gly215Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA344955"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a7f8b4e5-a0d8-4453-9aec-02e1ef070c33_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/81fc1966-fba0-41ba-913b-50677345f1a8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81fc1966-fba0-41ba-913b-50677345f1a8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a63ec7a-659b-4857-8674-d21de855401a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.2299C>T (p.Arg767Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253987"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/81fc1966-fba0-41ba-913b-50677345f1a8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d03b9ee8-7133-4d54-956a-93205d5d29be","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d03b9ee8-7133-4d54-956a-93205d5d29be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","allele":{"id":"https://genegraph.clinicalgenome.org/r/b94b2027-c96d-4a1c-bbf3-c6e9eec8d089","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.856C>T (p.Arg286Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394190396"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d03b9ee8-7133-4d54-956a-93205d5d29be_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/23840c1f-9d30-4ccf-9fc0-604a0cb12eb4_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aab31716-efb6-4f11-b2bc-d8630fe2994f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","rdfs:label":"p.Gly796Leufs*130","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/aab31716-efb6-4f11-b2bc-d8630fe2994f","type":"Family","rdfs:label":"p.Gly796Leufs*130","member":{"id":"https://genegraph.clinicalgenome.org/r/4e5c157f-7b4c-4ff9-97c8-da20fae7f8fa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","rdfs:label":"p.Gly796Leufs*130","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c3c6b68-ee08-4a75-999c-49c90bc019a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.2385_2386del (p.Gly796fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1371048"}},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7bf679c7-b0e0-4bbe-b298-024b0cfbbe46_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c3c6b68-ee08-4a75-999c-49c90bc019a2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":9,"phenotypes":"obo:HP_0011002","proband":{"id":"https://genegraph.clinicalgenome.org/r/4e5c157f-7b4c-4ff9-97c8-da20fae7f8fa"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/518e86f4-55db-4fc3-92f9-865307e5178c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","rdfs:label":"p.Gly215Arg","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/518e86f4-55db-4fc3-92f9-865307e5178c","type":"Family","rdfs:label":"p.Gly215Arg","member":{"id":"https://genegraph.clinicalgenome.org/r/1ffdbd82-6cf7-4c44-b1d8-bc4528cf66dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","rdfs:label":"p.Gly215Arg ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":61,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f570b117-404c-423f-b62b-6492c1c158ae"},"detectionMethod":"Whole-genome linkage analysis, followed by sequencing of CLCN7; exons and intron-exon boundaries of CLCN7 were sequenced\n","firstTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a7f8b4e5-a0d8-4453-9aec-02e1ef070c33_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"phenotypes":"obo:HP_0011002","proband":{"id":"https://genegraph.clinicalgenome.org/r/1ffdbd82-6cf7-4c44-b1d8-bc4528cf66dc"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/6b96e96f-069c-46c4-842f-9be1b82ed3ec_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","rdfs:label":"p.Pro249Leu ","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/6b96e96f-069c-46c4-842f-9be1b82ed3ec","type":"Family","rdfs:label":"p.Pro249Leu ","member":{"id":"https://genegraph.clinicalgenome.org/r/5cac5b34-4e02-4bf4-9616-e05aa4113e63","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","rdfs:label":"p.Pro249Leu ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":45,"allele":{"id":"https://genegraph.clinicalgenome.org/r/32da6a0c-d3b2-42e9-86ce-397c3ffdf2ac"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/785e37e7-fdf9-481a-a805-c1dadd79ce8e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","allele":{"id":"https://genegraph.clinicalgenome.org/r/32da6a0c-d3b2-42e9-86ce-397c3ffdf2ac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0011002","proband":{"id":"https://genegraph.clinicalgenome.org/r/5cac5b34-4e02-4bf4-9616-e05aa4113e63"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/00254ca6-f991-4caf-8e53-8e46f880fda4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00254ca6-f991-4caf-8e53-8e46f880fda4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21947783","allele":{"id":"https://genegraph.clinicalgenome.org/r/0db8f6bb-e4c0-4c29-9d69-797d9fc5366f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.869C>T (p.Ser290Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394190354"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/16d05406-60e0-4cc7-9aaf-76d592f75c63","type":"EvidenceLine","dc:description":"The functional evidence for this variant was already scored in another proband, but the 0.5 pts. is for the radiographic for this proband. Imaging showed increased bone density in jaws, dysplasia of the maxillary sinus, bone-within-bone iliac wings, and heightened bone density (femur).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16d05406-60e0-4cc7-9aaf-76d592f75c63_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21962762","allele":{"id":"https://genegraph.clinicalgenome.org/r/b94b2027-c96d-4a1c-bbf3-c6e9eec8d089"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/16d05406-60e0-4cc7-9aaf-76d592f75c63_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7bf679c7-b0e0-4bbe-b298-024b0cfbbe46","type":"EvidenceLine","dc:description":"Variant extends the protein over 100 amino acids, so I felt it was worthy of more points than a missense, but not as much as a null variant. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bf679c7-b0e0-4bbe-b298-024b0cfbbe46_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/81dc552a-535b-484f-b54d-8411dfc93c09","type":"EvidenceLine","dc:description":"Radiographic evidence indicates the sandwich vertebrae sign and \"Bone-in-Bone\" sign in pelvis. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81dc552a-535b-484f-b54d-8411dfc93c09_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30942407","allele":{"id":"https://genegraph.clinicalgenome.org/r/ca06d21f-25e6-4192-9381-8ef1d713d6ad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.2236T>G (p.Tyr746Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394185476"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/785e37e7-fdf9-481a-a805-c1dadd79ce8e","type":"EvidenceLine","dc:description":"Upgrading 0.5 due to radiographic evidence indicating \"Rugger Jersey Spine\" and \"Bone within Bone\" iliac wings. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/785e37e7-fdf9-481a-a805-c1dadd79ce8e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/785e37e7-fdf9-481a-a805-c1dadd79ce8e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ce7eef76-e4f1-45fd-bec6-3f672cf26fdb","type":"EvidenceLine","dc:description":"Variant leads to in-frame skipping of exon 23; not predicted to undergo NMD; removes less than 10 % of protein.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce7eef76-e4f1-45fd-bec6-3f672cf26fdb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30942407","allele":{"id":"https://genegraph.clinicalgenome.org/r/779e22e0-6ec0-4fae-887e-5200b46e2a9d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.2332-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394184998"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5f305428-f656-45bf-8eb0-a6aa1fa89430","type":"EvidenceLine","dc:description":"Upgrading to 0.5 due to radiographic evidence indicating sclerosis of the skull base and cortical thickening in the femurs. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f305428-f656-45bf-8eb0-a6aa1fa89430_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30229577","allele":{"id":"https://genegraph.clinicalgenome.org/r/9ff4d141-1e9d-469b-9bfb-1e94ae7bd2f5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.296A>G (p.Tyr99Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA264215"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4313f41e-dd89-4a1e-bafe-ec35f31397e4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4313f41e-dd89-4a1e-bafe-ec35f31397e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","allele":{"id":"https://genegraph.clinicalgenome.org/r/68985057-e6c3-4f86-a6f3-03009af740e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.2294G>A (p.Gly765Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394185210"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4313f41e-dd89-4a1e-bafe-ec35f31397e4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0ba0b8c7-e83c-4eb8-9ca1-55743179d2ae","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ba0b8c7-e83c-4eb8-9ca1-55743179d2ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11741829","allele":{"id":"https://genegraph.clinicalgenome.org/r/88e8a083-f5b5-40d5-ae23-bf8ae38417dd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001287.6(CLCN7):c.2062_2064del (p.Leu688del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695195462"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0ba0b8c7-e83c-4eb8-9ca1-55743179d2ae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant significantly reduced Cl- activity in comparison to the wild type (WILD) in HEK293K cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.6}],"evidenceStrength":"Definitive","sequence":7629,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/eSpvXgSe_zI","type":"GeneValidityProposition","disease":"obo:MONDO_0008156","gene":"hgnc:2025","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_23840c1f-9d30-4ccf-9fc0-604a0cb12eb4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}